Sensei Biotherapeutics, Inc. Profile Avatar - Palmy Investing

Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designe…

Biotechnology
US, Rockville [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Sensei Biotherapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Sensei Biotherapeutics, Inc. can't present revenue by segment

End of SNSE's Analysis
CIK: 1829802 CUSIP: 81728A108 ISIN: US81728A1088 LEI: - UEI: -
Secondary Listings
SNSE has no secondary listings inside our databases.